• A perfectly performed test on the wrong patient is still a dangerous laboratory error.
• Patient identification mistakes are high-yield on MLS exams because they test safety, quality systems, scope limits, and specimen acceptability at the same time.
• Many stems hinge on one discriminating clue: Can the specimen still be confidently linked to one patient? If not, the safest answer is usually to reject or hold pending policy-based resolution.
• Transfusion-service specimens use stricter rules because a labeling error can lead directly to incompatible blood issue.

1.1.1.1 Key terms

• Patient identifier: Unique data element used to match a specimen to one patient, such as full name, medical record number, date of birth, or accession-linked unique number per policy.
• At bedside/in presence labeling: Label applied immediately after collection while still with the patient or specimen source.
• Mislabeled specimen: Tube label contains identifiers, but they belong to another patient or do not match accompanying documentation.
• Unlabeled specimen: Tube has no patient identification.
• Partially labeled specimen: Tube has some but not all required identifiers.
• Specimen rejection: Laboratory refusal to process a specimen that fails acceptability criteria.
• Specimen hold: Temporary stop in testing or reporting while verification is performed.
• Positive patient identification: Active confirmation using identifiers from the patient or authorized source before collection.
• Recollection: New specimen obtained because original identity or integrity cannot be assured.
• LIS mismatch: Disagreement between specimen label and electronic order record.
• Chain of identity: Continuous traceable link from patient to specimen to result.
• Wrong blood in tube (WBIT): Blood specimen labeled as one patient but actually collected from another; critical in transfusion service.

1.1.1.2 Must-know facts

• Two independent patient identifiers are commonly required; local policy defines acceptable combinations.
• Room number and bed number are poor identifiers and are often not acceptable as primary identifiers.
• Time and collector initials may be required labeling elements even when they are not the core patient identifiers.
• An unlabeled blood specimen is generally not safe to relabel after it leaves the bedside.
• A specimen with conflicting identifiers is higher risk than one with a missing optional field.
• Pretransfusion specimens have the strictest acceptance rules in most laboratories.
• The MLS role is to enforce specimen acceptance policy, document the nonconformance, and escalate when needed.
• Previous matching results do not prove current specimen identity.
• Critical test urgency does not eliminate identification rules; emergency exceptions must follow policy, not improvisation.

flowchart LR
A[Patient present] --> B[Positive identification]
B --> C[Collection]
C --> D[Immediate tube labeling]
D --> E[Order-label match]
E --> F[Lab receipt verification]
F --> G[Testing and release]
X[Broken link] --> Y[Hold or reject specimen]

1.1.1.3 Foundational rule: what makes a specimen identifiable enough to test?

A Explanation

The main decision conflict is simple: Do you have enough trustworthy identity information to proceed, or must you stop? On exam stems, the resolving rule is whether the specimen container itself carries the required patient identifiers and whether those identifiers match the order and available source documents. A specimen is not acceptable just because the requisition is complete, the collector sounds confident, or prior results match. The tube must be linked to one patient without ambiguity.

WHY THIS IS TESTED: Examiners use labeling questions to test whether you prioritize patient safety over convenience. The correct MLS action is usually determined by one rule: identity must be established on the specimen, not reconstructed after the fact.

Choose testing when the tube label contains the required identifiers and matches the LIS/order. Reject or hold when the tube is unlabeled, bears another patient's identifiers, contains insufficient identifiers per policy, or conflicts with the electronic order. When a stem includes a missing date/time or collector initials, decide whether the defect threatens patient identity or mainly affects traceability/documentation. Identity failures are high-risk hard stops. Documentation gaps may be policy-dependent and sometimes correctable before release.

For ASCP-style questions, the highest-yield distinction is this: missing patient identity data on the tube is worse than missing ancillary collection information. If the patient link is broken, recollection is usually required.

B Worked example

A 68-year-old inpatient with diabetes, chronic kidney disease, and anemia has a lavender-top EDTA tube sent for a CBC. The requisition lists full name, medical record number, and date of birth. The tube label contains the patient's full name and room number, but no medical record number. Collection time is present. The floor calls and says, “It is definitely the right patient; this is his usual morning draw.” A previous day's CBC is consistent with the current clinical picture.

Reasoning chain: Identify task - specimen acceptability based on labeling. Extract key facts - tube lacks one required independent patient identifier, requisition is complete, and prior similar results are a distracting clue. Apply rule - specimen identity must be sufficient on the tube itself; room number is not a reliable substitute for a unique identifier. Eliminate distractors - do not accept based on verbal assurance, do not complete the label in the lab, do not use prior matching results to infer identity. Verify - safest next step is reject or hold for recollection per policy because the patient-specimen link is incomplete.

C Exam trap

D Checkpoint

Question: Which specimen is most appropriate to accept for testing under standard identity logic, assuming local policy requires two patient identifiers on the tube?

1. Tube labeled with patient full name and room number; requisition has full demographics.
2. Tube labeled with full name and medical record number; requisition has matching identifiers but collector initials are missing.
3. Tube unlabeled; requisition attached with full name, medical record number, and collection time.
4. Tube labeled with full name and medical record number that differ from the electronic order by one digit.

Answer: B

• A: Tempting because there are two pieces of information, but room number is not a reliable patient identifier.
• B: Correct because the tube carries two matching patient identifiers; missing collector initials is a traceability issue, not a broken patient link.
• C: Tempting because the requisition is complete, but an unlabeled tube cannot be safely linked to the patient.
• D: Tempting because the discrepancy is small, but even a one-digit mismatch breaks exact identity matching.

1.1.1.4 Foundational rule: bedside labeling timing and why prelabeling fails

A Explanation

The decision conflict here is whether a specimen can still be trusted if the collector did not label it immediately in the patient's presence. The single rule that resolves the conflict is that the safest time to label is immediately after collection, before leaving the patient or source. Prelabeling empty tubes or delaying labeling until later creates an interval in which specimen identity can be swapped, forgotten, or mixed with another patient's tubes.

WHY THIS IS TESTED: Board questions often present “almost correct” workflows. The collector verified the wristband, drew the blood correctly, and planned to label the tubes at the desk. The exam asks whether that delay is acceptable. It is not the venipuncture skill being tested; it is the integrity of the identity chain.

Choose the workflow that verifies identity using approved identifiers, collects the specimen, then labels the tube immediately while still with the patient. Reject workflows that rely on memory, preprinted labels placed on the counter before collection, or later relabeling after transport. The risk is not theoretical. Multiple correctly drawn tubes become unsafe once their patient assignment depends on recollection rather than direct labeling.

This is also where upcoming topics connect. Collection Tubes & Additives will teach you which tube to draw; this lesson teaches that even the right tube is still wrong if labeled at the wrong time. See Fig 2 for the visual sequence that exam stems expect you to recognize.

B Worked example

A 27-year-old postpartum patient with hypertension and iron deficiency anemia is drawn for CBC and CMP. The phlebotomist verifies the wristband correctly but collects tubes for two roommates during a busy round, planning to label both sets at the nursing station because the patient was sleeping. On receipt, both sets appear properly labeled, but a nursing note documents the delayed labeling process. The potassium on one specimen is unexpectedly high, which is a distracting clue that may make the issue seem analytic rather than identity-related.

Reasoning chain: Identify task - determine whether the specimen identity chain remained valid. Extract key facts - delayed labeling occurred after collecting from more than one patient. Apply rule - labeling later at the station breaks direct bedside association and creates risk of wrong-patient assignment. Eliminate distractors - do not focus first on the potassium value, and do not accept because labels are now present. Verify - the primary problem is preanalytic identity integrity; specimens may require rejection and recollection according to policy.

C Exam trap

D Checkpoint

Question: Which collection workflow best preserves specimen identity?

1. Print labels for all morning draws, place them on the tray, collect all tubes, and label at the end of the round.
2. Verify two patient identifiers, collect one patient's tubes, label immediately in the patient's presence, then proceed to the next patient.
3. Collect the specimen, carry it to the nursing station, and label it while the encounter is still fresh in memory.
4. Prelabel tubes before entering the room if the patient has a wristband and electronic order.

Answer: B

• A: Tempting because it seems efficient, but batching unlabeled tubes creates a classic wrong-patient risk.
• B: Correct because identity is verified and preserved without any unlabeled interval after collection.
• C: Tempting because the delay is short, but memory-based labeling is not a secure identity process.
• D: Tempting because labels match the order, but prelabeling empty tubes allows tubes to be attached to the wrong collected specimen.

flowchart TD
A[Specimen received] --> B{Tube has required patient identifiers?}
B -- No --> C[Reject or recollect]
B -- Yes --> D{Identifiers match order/LIS?}
D -- No --> E[Hold and investigate mismatch]
D -- Yes --> F{Missing time/collector info only?}
F -- Yes --> G[Policy-based correction or delayed release]
F -- No --> H[Accept for testing]

1.1.1.5 Application: accept, hold, reject, or recollect?

A Explanation

Now the decision becomes operational: Which defects permit temporary hold and clarification, and which demand immediate rejection/recollection? The single finding that resolves most stems is whether the original specimen can still be safely tied to one patient without post hoc guesswork. If yes, you may hold and clarify. If no, reject.

WHY THIS IS TESTED: MLS candidates must make safe next-step decisions, not just memorize definitions. Questions often give several plausible actions: call the nurse, relabel the tube, run the test and append a comment, or reject. The best answer depends on whether patient identity itself is intact.

Accept when required identifiers are present and fully match. Hold when there is a discrepancy that may represent an order-entry or accession issue but the original label still clearly identifies one patient; for example, a correct bedside-labeled tube with a LIS transposition error discovered at receipt. Reject when the specimen is unlabeled, labeled with another patient's identity, partially labeled below policy minimum, or collected in a way that broke the identity chain. Recollect when the original identity cannot be restored confidently from the specimen itself.

Do not confuse “urgent test” with “acceptable specimen.” A stat troponin, blood gas, type and screen, or coagulation specimen still requires valid identification. Urgency changes communication priority, not safety rules. See Fig 3 for the accept/hold/reject sorting logic.

B Worked example

A 73-year-old man with sepsis, atrial fibrillation, and chronic liver disease has a blue-top citrate tube sent for PT/INR. The tube is labeled with full name and medical record number. The electronic order shows the same full name, but the medical record number differs by one transposed digit. Collection date/time and phlebotomist initials are present. The patient is on warfarin, and the unit calls repeatedly because the result is needed quickly before an invasive procedure.

Reasoning chain: Identify task - determine immediate laboratory disposition. Extract key facts - the tube itself identifies one specific patient, but the LIS/order mismatch suggests possible accession or order-entry error. Apply rule - because the tube is labeled and not anonymous, identity may still be resolvable through investigation; do not test-and-release automatically, but also do not relabel casually. Eliminate distractors - urgency does not justify proceeding without verification; recollection may be needed if discrepancy cannot be resolved. Verify - the safest next step is hold the specimen and investigate the mismatch according to policy, escalating if unresolved.

C Exam trap

D Checkpoint

Question: A serum tube has full name and MRN that match each other on the tube, but the electronic order contains the same name with a different MRN. What is the most appropriate immediate laboratory action?

1. Run the test and report because the patient name matches.
2. Rewrite the tube label to match the order.
3. Hold the specimen and investigate the discrepancy according to policy before testing/release.
4. Discard the specimen without documentation because patient harm could occur.

Answer: C

• A: Tempting because partial agreement exists, but exact matching is required before release.
• B: Tempting because it seems efficient, but the laboratory must not relabel a specimen to force agreement without authorized resolution.
• C: Correct because the specimen identifies a patient, yet a mismatch exists that must be resolved before proceeding.
• D: Tempting because safety matters, but undocumented disposal skips required investigation and traceability.

flowchart TD
A[Tube and order disagree] --> B{Tube identifies one patient clearly?}
B -- No --> C[Reject and recollect]
B -- Yes --> D[Hold specimen]
D --> E[Review accession entry and source documents]
E --> F{Resolved per policy?}
F -- Yes --> G[Proceed with traceable correction]
F -- No --> H[Recollect and escalate]

1.1.1.6 Application: special risk situations and transfusion-service strictness

A Explanation

The decision conflict here is whether all specimens are treated equally when labeling is imperfect. They are not. The single rule that resolves these stems is that the higher the downstream patient risk, the lower the tolerance for any identity defect. Pretransfusion testing, blood bank specimens, and some irreplaceable specimens often have stricter institutional rules, but blood bank labeling is the classic exam focus.

WHY THIS IS TESTED: MLS exams emphasize safe scope. In transfusion medicine, a mislabeled or uncertain specimen can lead to incompatible blood issue. Therefore, answers that might seem “reasonable” for routine chemistry become clearly unsafe in blood bank contexts.

For a type and screen, type and crossmatch, or pretransfusion specimen, missing identifiers, conflicting identifiers, or absent required collection details typically trigger rejection and recollection. Do not “correct” the label from the requisition, and do not accept based on prior ABO/Rh history alone. Previous blood type is a useful comparison, not proof of current specimen identity. In many systems, even a near-perfect specimen with one missing required field is unacceptable for transfusion testing because the consequence of error is so severe.

Board stems may also test irreplaceable non-blood specimens, such as CSF or tissue, where policy may differ and escalation is necessary rather than routine discard. The key is still scope: you do not invent exceptions. You follow policy, document, and escalate.

B Worked example

A 59-year-old trauma patient with prior transfusions, coronary artery disease, and chronic anemia has a stat type and screen ordered before surgery. The pink-top specimen label shows full name and MRN, but the date of birth is absent even though local blood bank policy requires full name, MRN, DOB, collection date/time, and collector ID on pretransfusion specimens. The nurse states that the patient is unstable and that the historic blood type in the LIS matches the wristband. A normal platelet count on the CBC is included as a distracting detail.

Reasoning chain: Identify task - pretransfusion specimen acceptability. Extract key facts - missing required blood bank identifier, urgent situation, prior blood type available, local strict policy given. Apply rule - in transfusion-service testing, required labeling elements are enforced strictly because consequences are severe. Eliminate distractors - do not accept using historical blood type; do not add DOB in the lab; do not make an emergency release decision outside role. Verify - reject the specimen for recollection and follow policy-based communication/escalation.

C Exam trap

D Checkpoint

Question: Which statement best reflects MLS handling of a mislabeled pretransfusion specimen?

1. Accept if the patient's prior ABO/Rh type matches the current label.
2. Rewrite the missing identifier from the wristband if the nurse is present.
3. Reject and request recollection according to blood bank policy.
4. Issue uncrossmatched blood independently because the specimen defect creates urgency.

Answer: C

• A: Tempting because history can support correlation, but it cannot prove current specimen identity.
• B: Tempting because bedside sources exist, but post-collection lab relabeling is not a safe substitute for proper collection labeling.
• C: Correct because pretransfusion specimens require strict compliance with identity policy.
• D: Tempting because emergency release is a real process, but authorizing it independently is outside entry-level MLS scope unless explicit protocol assigns that step.

1.1.1.7 Integration: documentation, communication, and scope-safe escalation

A Explanation

The final decision conflict is not whether there is an error, but what the MLS should do next within scope once the error is recognized. The single rule is this: identify the defect, prevent unsafe testing/reporting, document the nonconformance, and escalate according to policy. Do not create your own workaround.

WHY THIS IS TESTED: MLS questions often include plausible but overreaching actions such as changing labels, authorizing clinical exceptions, or releasing with a comment. The exam wants the safest laboratory action that preserves traceability and stays within entry-level role boundaries.

The scope-safe sequence is: hold or reject the specimen, notify the appropriate source area, document the exact problem, and escalate unresolved or high-risk issues. Documentation should include what was wrong, who was notified, when, and what disposition occurred. This matters for patient safety, quality indicators, and regulatory traceability. In some institutions, there may be a specific policy pathway for exceptions involving irreplaceable specimens or witnessed relabeling by the collector. On the exam, if policy is not explicitly given, do not assume a permissive exception exists.

Do not release results from an unacceptable specimen simply because the values “look right.” Analytic accuracy cannot compensate for identity uncertainty. See Fig 1 again: once the identity chain breaks, downstream quality no longer rescues the result. Also see Fig 4 for the mismatch investigation pathway.

B Worked example

A 44-year-old emergency department patient with asthma, obesity, and dehydration has a green-top plasma specimen for chemistry testing. The accessioner notices the tube label is complete, but the accompanying paper requisition lists a different date of birth. The nurse says the paper form was likely printed for the wrong patient and asks the lab to “just use the tube label since the CMP is needed quickly.” The glucose is critically elevated on repeat instrument check, a distracting clue that may tempt immediate release.

Reasoning chain: Identify task - determine appropriate MLS action within scope. Extract key facts - labeled specimen, conflicting documentation, urgent request, critical-appearing value. Apply rule - do not release from a specimen with unresolved identity discrepancy; hold and investigate because a wrong form or wrong tube remains possible. Eliminate distractors - do not diagnose hyperglycemia, do not release with a note, and do not rewrite the requisition yourself. Verify - safest action is to hold the result, investigate/document the discrepancy, and escalate if unresolved.

C Exam trap

D Checkpoint

Question: After identifying an unacceptable unlabeled specimen, what is the most appropriate MLS action?

1. Label it using the requisition because the specimen source is obvious.
2. Hold the specimen, notify the collection area, document the nonconformance, and request recollection per policy.
3. Run the test and suppress the result until the clinician calls.
4. Discard it immediately without entering anything into the LIS to avoid confusion.

Answer: B

• A: Tempting because it seems to solve the problem quickly, but it creates an unsafe laboratory relabeling event.
• B: Correct because it protects patient safety, preserves traceability, and stays within MLS scope.
• C: Tempting because analysis could save time, but testing an unacceptable specimen wastes resources and may create reporting risk.
• D: Tempting because the specimen is unusable, but failing to document the nonconformance breaks quality tracking and communication.

• Most common wrong answer and why: “Accept because the requisition is complete.” Tempting because the paperwork looks correct. Wrong because the specimen container itself must securely identify the patient.
• Looks similar but isn't: Missing collector initials versus missing MRN. Both are incomplete labels, but one threatens traceability while the other may break patient identity.
• If the stem says the tube is unlabeled, think reject/recollect, not add a label from the order.
• If the stem says identifiers on the tube and LIS differ, think hold and investigate before testing or release.
• If the stem says the specimen is for blood bank/pretransfusion use, think strictest identity enforcement.
• If the stem says the patient is a stat or critical case, think urgency changes communication priority, not identity rules.
• If the stem says the collector wants to label after leaving the bedside, think broken chain of identity.
• If the stem says historical results match, think reassuring noise, not proof.

Related future trap: in Collection Tubes & Additives, the specimen may be correctly identified but analytically invalid because the wrong tube was used. In this lesson, the identity problem comes first; a correctly selected tube still cannot be tested if the patient link is unsafe.

Related future trap: in Transport, Storage & Processing, the specimen may be properly labeled but rejected for delay, temperature, or light exposure. Learn to separate who the specimen belongs to from whether the specimen remained stable.

• Unlabeled tube -> identity lost, not merely incomplete paperwork
• Room number -> location clue, not reliable patient identifier
• Matching requisition with unlabeled tube -> still reject/recollect
• Missing collector initials -> traceability issue, not automatic wrong-patient proof
• One-digit MRN mismatch -> exact match failure, investigate before release
• Delayed labeling after leaving bedside -> broken chain of identity
• Historical matching result -> reassurance only, never identity proof
• Urgent test request -> speeds communication, not specimen acceptance rules
• Blood bank specimen -> strictest labeling enforcement
• MLS scope -> hold/reject/document/escalate, not invent exceptions
• Tube first -> specimen label determines initial acceptability
• Mismatch with intact tube labeling -> hold-and-investigate, not automatic relabel
• Correct tube type but wrong identity -> still unusable
• Critical value from uncertain specimen -> do not report until identity is resolved